Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management
Authors
Keywords
Statin, High Density Lipoprotein Cholesterol, Fenofibrate, Ezetimibe, Cholesteryl Ester Transfer Protein
Journal
DRUGS
Volume 73, Issue 4, Pages 327-339
Publisher
Springer Nature America, Inc
Online
2013-03-11
DOI
10.1007/s40265-013-0023-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postprandial Dysmetabolism: The Missing Link Between Diabetes and Cardiovascular Events?
- (2013) David Bell et al. Endocrine Practice
- American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
- (2013) Paul Jellinger et al. Endocrine Practice
- Evaluation of Low-Density Lipoprotein Particle Number Distribution in Patients With Type 2 Diabetes Mellitus With Low-Density Lipoprotein Cholesterol
- (2012) Hector Malave et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
- (2012) Sarah Parish et al. CIRCULATION
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis Comparing Mediterranean to Low-Fat Diets for Modification of Cardiovascular Risk Factors
- (2011) Alain J. Nordmann et al. AMERICAN JOURNAL OF MEDICINE
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients
- (2010) Harold E. Bays et al. CURRENT MEDICAL RESEARCH AND OPINION
- Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease
- (2010) Michael J. Haas et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
- (2010) Todd C. Villines et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- (2009) J. H. Contois et al. CLINICAL CHEMISTRY
- Whatʼs the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
- (2009) Harold E Bays et al. CURRENT OPINION IN LIPIDOLOGY
- Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
- (2009) S. N. Rajpathak et al. DIABETES CARE
- Dyslipidemia in type 2 diabetes mellitus
- (2009) Arshag D Mooradian Nature Reviews Endocrinology
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media Thickness
- (2009) Allen J. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy
- (2008) Ronald B. Goldberg ARCHIVES OF INTERNAL MEDICINE
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- (2008) Harold E. Bays et al. ARCHIVES OF INTERNAL MEDICINE
- Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
- (2008) J. D. Brunzell et al. DIABETES CARE
- Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
- (2008) V. A. Fonseca et al. DIABETES CARE
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes
- (2008) Jerome L. Fleg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
- (2008) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity-related Changes in High-density Lipoprotein Metabolism
- (2008) Arshag D. Mooradian et al. Obesity
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started